A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer

Published:2014-12 Issue:18 Volume:50 Page:3136-3144
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hickish Tamas,Cassidy Jim,Propper David,Chau Ian,Falk Stephen,Ford Hugo,Iveson Tim,Braun Michael,Potter Vanessa,Macpherson Iain R.,Finnigan Helen,Lee Chooi,Jones Hilary,Harrison Mark

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer;Mayer;Cancer,1993

2. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2;Maurer;Hum Pathol,1998

3. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery;Lee;Eur J Cancer,2002

4. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas;Lee;Clin Cancer Res,2006

5. Somatic mutations of the ERBB4 kinase domain in human cancers;Soung;Int J Cancer,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal cancer harboring EGFR kinase domain duplication response to EGFR tyrosine kinase inhibitors;The Oncologist;2024-05-31

2. Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid model;Biomedicine & Pharmacotherapy;2023-11

3. Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer;Current Treatment Options in Oncology;2021-06-07

4. Strategies to tackle RAS-mutated metastatic colorectal cancer;ESMO Open;2021-06

5. Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance;Gastroenterology Report;2020-06-01